Literature DB >> 7724601

Conditional transformation of a pancreatic beta-cell line derived from transgenic mice expressing a tetracycline-regulated oncogene.

S Efrat1, D Fusco-DeMane, H Lemberg, O al Emran, X Wang.   

Abstract

Conditional oncogene expression in transgenic mice is of interest for studying the oncoprotein requirements during tumorigenesis and for deriving cell lines that can be induced to undergo growth arrest and enhance their differentiated functions. We utilized the bacterial tetracycline (Tet)-resistance operon regulatory system (tet) from Tn10 of Escherichia coli to control simian virus 40 (SV40) large tumor (T) antigen (TAg) gene expression and to generate conditionally transformed pancreatic beta cells in transgenic mice. A fusion protein containing the tet repressor (tetR) and the activating domain of the herpes simplex virus protein VP16, which converts the repressor into a transcription activator, was produced in beta cells of transgenic mice under control of the insulin promoter. In a separate lineage of transgenic mice, the TAg gene was introduced under control of a tandem array of tet operator sequences and a minimal promoter, which by itself is not sufficient for gene expression. Mice from the two lineages were then crossed to generate double-transgenic mice. Expression of the tetR fusion protein in beta cells activated TAg transcription, resulting in the development of beta-cell tumors. Tumors arising in the absence of Tet were cultured to derive a stable beta-cell line. Cell incubation in the presence of Tet led to inhibition of proliferation, as shown by decreased BrdUrd and [3H]thymidine incorporation. The Tet derivative anhydrotetracycline showed a 100-fold stronger inhibition compared with Tet. When administered in vivo, Tet efficiently inhibited beta-cell proliferation. These findings indicate that transformed beta cells selected for growth during a tumorigenesis process in vivo maintain a dependence on the continuous presence of the TAg oncoprotein for their proliferation. This system provides an approach for generation of beta-cell lines for cell therapy of diabetes as well as conditionally transformed cell lines from other cell types of interest.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7724601      PMCID: PMC42210          DOI: 10.1073/pnas.92.8.3576

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  14 in total

1.  Intervening sequences increase efficiency of RNA 3' processing and accumulation of cytoplasmic RNA.

Authors:  M T Huang; C M Gorman
Journal:  Nucleic Acids Res       Date:  1990-02-25       Impact factor: 16.971

Review 2.  Dissecting multistep tumorigenesis in transgenic mice.

Authors:  D Hanahan
Journal:  Annu Rev Genet       Date:  1988       Impact factor: 16.830

3.  Bidirectional activity of the rat insulin II 5'-flanking region in transgenic mice.

Authors:  S Efrat; D Hanahan
Journal:  Mol Cell Biol       Date:  1987-01       Impact factor: 4.272

4.  Heritable formation of pancreatic beta-cell tumours in transgenic mice expressing recombinant insulin/simian virus 40 oncogenes.

Authors:  D Hanahan
Journal:  Nature       Date:  1985 May 9-15       Impact factor: 49.962

5.  Direct derivation of conditionally immortal cell lines from an H-2Kb-tsA58 transgenic mouse.

Authors:  P S Jat; M D Noble; P Ataliotis; Y Tanaka; N Yannoutsos; L Larsen; D Kioussis
Journal:  Proc Natl Acad Sci U S A       Date:  1991-06-15       Impact factor: 11.205

6.  RNA polymerase II transcription blocked by Escherichia coli lac repressor.

Authors:  U Deuschle; R A Hipskind; H Bujard
Journal:  Science       Date:  1990-04-27       Impact factor: 47.728

7.  Beta-cell lines derived from transgenic mice expressing a hybrid insulin gene-oncogene.

Authors:  S Efrat; S Linde; H Kofod; D Spector; M Delannoy; S Grant; D Hanahan; S Baekkeskov
Journal:  Proc Natl Acad Sci U S A       Date:  1988-12       Impact factor: 11.205

8.  Conversion of the lac repressor into an allosterically regulated transcriptional activator for mammalian cells.

Authors:  M A Labow; S B Baim; T Shenk; A J Levine
Journal:  Mol Cell Biol       Date:  1990-07       Impact factor: 4.272

9.  Structural requirements of tetracycline-Tet repressor interaction: determination of equilibrium binding constants for tetracycline analogs with the Tet repressor.

Authors:  J Degenkolb; M Takahashi; G A Ellestad; W Hillen
Journal:  Antimicrob Agents Chemother       Date:  1991-08       Impact factor: 5.191

10.  Temporal control of gene expression in transgenic mice by a tetracycline-responsive promoter.

Authors:  P A Furth; L St Onge; H Böger; P Gruss; M Gossen; A Kistner; H Bujard; L Hennighausen
Journal:  Proc Natl Acad Sci U S A       Date:  1994-09-27       Impact factor: 11.205

View more
  57 in total

Review 1.  Conditional control of gene expression in the mammary gland.

Authors:  P A Furth
Journal:  J Mammary Gland Biol Neoplasia       Date:  1997-10       Impact factor: 2.673

2.  An episomal vector for stable tetracycline-regulated gene expression.

Authors:  M Jost; C Kari; U Rodeck
Journal:  Nucleic Acids Res       Date:  1997-08-01       Impact factor: 16.971

3.  Tet-system for the regulation of gene expression during embryonic development.

Authors:  L M Fedorov; O Y Tyrsin; V Krenn; E V Chernigovskaya; U R Rapp
Journal:  Transgenic Res       Date:  2001-06       Impact factor: 2.788

4.  Creation of a reversible on/off system for site-specific in vivo control of exogenous gene activity in the renal glomerulus.

Authors:  M Kitamura
Journal:  Proc Natl Acad Sci U S A       Date:  1996-07-09       Impact factor: 11.205

5.  Modeling of encapsulated cell systems.

Authors:  Jeffrey D Gross; I Constantinidis; A Sambanis
Journal:  J Theor Biol       Date:  2006-08-26       Impact factor: 2.691

6.  The use of gating technology in bioengineering insulin-secreting cells from embryonic stem cells.

Authors:  Enrique Roche; Mark M Burcin; Sybille Esser; Manfred Rüdiger; Bernat Soria
Journal:  Cytotechnology       Date:  2003-03       Impact factor: 2.058

7.  Differentiation of the immortalized adult neuronal progenitor cell line HC2S2 into neurons by regulatable suppression of the v-myc oncogene.

Authors:  M Hoshimaru; J Ray; D W Sah; F H Gage
Journal:  Proc Natl Acad Sci U S A       Date:  1996-02-20       Impact factor: 11.205

Review 8.  Diverse strategies for tetracycline-regulated inducible gene expression.

Authors:  P E Shockett; D G Schatz
Journal:  Proc Natl Acad Sci U S A       Date:  1996-05-28       Impact factor: 11.205

9.  Destruction of conditional insulinoma cell lines in NOD mice: a role for autoimmunity.

Authors:  P Cattan; D Rottembourg; S Cottet; I Tardivel; P Dupraz; B Thorens; C Boitard; J C Carel
Journal:  Diabetologia       Date:  2003-03-25       Impact factor: 10.122

10.  Pancreatic beta-cell overexpression of the glucagon receptor gene results in enhanced beta-cell function and mass.

Authors:  Richard W Gelling; Patricia M Vuguin; Xiu Quan Du; Lingguang Cui; John Rømer; Raymond A Pederson; Margarita Leiser; Heidi Sørensen; Jens J Holst; Christian Fledelius; Peter B Johansen; Norman Fleischer; Christopher H S McIntosh; Erica Nishimura; Maureen J Charron
Journal:  Am J Physiol Endocrinol Metab       Date:  2009-07-14       Impact factor: 4.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.